Zoetis Pharmaceutical Research Profile
Key Indicators
- Authorised Capital ₹ 700.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 354.24 Cr
as on 16-11-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 75.25 Cr
as on 16-11-2024
- Revenue 22.29%
(FY 2023)
- Profit 48.35%
(FY 2023)
- Ebitda 25.90%
(FY 2023)
- Net Worth 2.54%
(FY 2023)
- Total Assets 3.67%
(FY 2023)
About Zoetis Pharmaceutical Research
The Corporate was formerly known as Warner-Lambert India Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 700.00 Cr and a paid-up capital of Rs 354.24 Cr.
The company currently has active open charges totaling ₹75.25 Cr.
The Key Managerial Personnel (KMP) at Zoetis Pharmaceutical Research Private Limited India is Pooja Rajan as COMPANY SECRETARY. Deepak Jain, Anurag Sood, Sudeepta Neogi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24117MH1995FTC084206
- Company No.
084206
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
02 Jan 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Zoetis Pharmaceutical Research Private Limited offer?
Zoetis Pharmaceutical Research Private Limited offers a wide range of products and services, including Content Writing Service, Research Development Services, Business Planning and Management, Business Consultant.
Who are the key members and board of directors at Zoetis Pharmaceutical Research?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pooja Rajan | Company Secretary | 01-Dec-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Sood  | Whole-Time Director | 06-Mar-2023 | Current |
| Deepak Jain | Whole-Time Director | 14-Nov-2022 | Current |
| Sudeepta Neogi | Whole-Time Director | 26-Mar-2021 | Current |
| Kavita Bhavnani | Director | 24-Nov-2012 | Current |
Financial Performance and Corporate Structure Insights of Zoetis Pharmaceutical Research.
Zoetis Pharmaceutical Research Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 22.29% increase. The company also saw a substantial improvement in profitability, with a 48.35% increase in profit. The company's net worth moved up by a moderate rise of 2.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Zoetis Pharmaceutical Research?
In 2023, Zoetis Pharmaceutical Research had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Anz Grindlays Bank Ltd. Creation Date: 27 Jul 1998 | ₹25.75 Cr | Open |
Anz Grindlays Bank Ltd. Creation Date: 27 Jul 1998 | ₹25.75 Cr | Open |
The Hongkong And Shangai Bank Co.Ltd. Creation Date: 10 Oct 1995 | ₹15.75 Cr | Open |
How Many Employees Work at Zoetis Pharmaceutical Research?
Zoetis Pharmaceutical Research has a workforce of 53 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zoetis Pharmaceutical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zoetis Pharmaceutical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
